Comparison of Botox<sup>®</sup> or Prosigne<sup>®</sup> and Facial Nerve Blockade as Adjuvant in Chronic Migraine

Journals Menu

Follow SCIRP

ISSN Print: 1937-6871
ISSN Online: 1937-688X
www.scirp.org/journal/jbise
E-mail: jbise@scirp.org

"Comparison of Botox^® or Prosigne^® and Facial Nerve Blockade as Adjuvant in Chronic Migraine"
written by Gabriela R. Lauretti, Christiane P. Rosa, Antônio Kitayama, Bruno C. P. Lopes,
published by Journal of Biomedical Science and Engineering, Vol.7 No.8, 2014

has been cited by the following article(s):

[1]	Impact of the botulinum-A toxin on prevention of adult migraine disorders
	2020

[2]	Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine
	BMJ open, 2019

[3]	Botulinum toxins for the prevention of migraine in adults
	Cochrane Database of Systematic Reviews, 2018

[1]	Impact of the botulinum-A toxin on prevention of adult migraine disorders Journal of Integrative Neuroscience, 2020 DOI:10.31083/j.jin.2020.01.1240

[2]	Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine BMJ Open, 2019 DOI:10.1136/bmjopen-2018-027953

[3]	Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine BMJ Open, 2019 DOI:10.1136/bmjopen-2018-027953

[4]	Botulinum toxins for the prevention of migraine in adults Cochrane Database of Systematic Reviews, 2018 DOI:10.1002/14651858.CD011616.pub2

Follow SCIRP